Table 2: Salivary organic protective components in patients with
reflux esophagitis (RE) and control group (CTRL) (Mean ± SEM)
Parameter |
Basal |
Mastication |
Tubing |
Balloon |
Initial NaCl |
HCl |
HCl/pepsin |
Final NaCl |
Glycoconjugate
RE (mg/min) |
0.56
±0.09 ⃰ |
1.04
±0.16 ⃰ |
5.43
±1.27 ⃰ |
5.21
±0.91 ⃰ |
5.87
±0.97 ⃰ |
7.14
± 1.03 ⃰ |
7.18
± 1.19 ⃰ |
6.92
± 0.97 ⃰ |
Glycoconjugate
CTRL (mg/min) |
0.75
± 0.08 |
1.50
± 0.20 |
8.30
± 0.99 |
12.67
± 1.59 |
11.68
± 1.68 |
9.16
± 1.32 |
11.75
± 1.70 |
11.19
± 1.65 |
Protein RE (mg/min) |
2.14
± 0.24 |
3.13
± 0.37 |
5.29
± 0.88 |
6.10
± 1.26 |
5.82
± 1.29 ⃰ |
6.40
± 1.19 ⃰ ⃰ |
6.23
± 1.39 |
5.96
± 1.09 |
Protein CTRL (mg/min) |
1.77
± 0.26 |
3.47
± 0.44 |
6.69
± 0.72 |
7.96
± 0.83 |
7.60
± 0.89 |
8.75
± 1.06 |
7.11
± 0.88 |
6.72
± 0.75 |
TGFa RE
(ng/min) |
0.08
± 0.04 |
0.14
± 0.03 |
0.18
± 0.07 |
0.22
± 0.11 |
0.19
± 0.05 |
0.19
± 0.03 |
0.19
± 0.05 |
0.23
± 0.07 |
TGFa CTRL
(ng/min) |
0.08
± 0.03 |
0.20
± 0.07 |
0.21
± 0.08 |
0.28
± 0.05 |
0.18
± 0.04 |
0.22
± 0.04 |
0.24
± 0.06 |
0.17
± 0.03 |
PGE2
RE (pg/min) |
105
± 42.70 |
279
± 124.00 |
217
± 64.40 |
262
± 73.80 |
313
± 94.00 |
314
± 116.00 |
389
± 115.00 |
227
± 61.10 |
PGE2
CTRL (pg/min) |
65
± 13.90 |
179
± 50.40 |
182
± 38.60 |
246
± 58.30 |
161
± 30.90 |
165
± 62.50 |
230
± 94.70 |
146
± 36.40 |
* = p<0.05; **= p<0.01 respectively, significant
p values in patients with RE when compared to CTRL group.